Please ensure Javascript is enabled for purposes of website accessibility
NorCal Doctor: Not Everyone Needs COVID-19 Testing
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
April 10, 2020

Share

“We almost don’t need them for everybody,” Dr. Roberta Luskin-Hawk says of COVID-19 tests.
Her reasoning is explained below, but it also comes from a wealth of medical experience. She is an infectious disease specialist who worked with Dr. Anthony Fauci in Chicago during the AIDS epidemic. And she is the chief executive for St. Joseph Health in Eureka.
Her hospital just began a clinical trial for the antiviral drug remdesivir and has enrolled one patient so far.
GV Wire spoke to Luskin-Hawk via Zoom on Friday morning.

Q&A with Dr. Luskin-Hawk

GV Wire: Abbott Labs is producing about 50,000 COVID-19 test kits a day. Is it likely we’ll ever get enough test kits for everyone?

A test for someone with no symptoms is pretty meaningless because they could pick it up a week from now. But tests that are also in development are these antibody tests, which will be a blood test that will be simpler and easier to do. It will be for someone who has already been exposed and may have some immunity. So I think there will be combinations of testing, but the need to test for the virus itself is not something we need to do in every person.

Of all the clinical trials you could have joined, why remdesivir?

As an infectious disease doctor, I was intrigued by something that had specific antiviral activity. But I think the other compelling anecdote and it is strictly related to one case which is not sufficient to know how the drug works, but the first case report in the U.S., from Washington state was a man who was in ICU and was given remdesivir. This was reported in the New England Journal of Medicine … and the patient went on to do well.

What does remdesivir do?

These drugs interfere with (COVID-19) multiplying. This particular drug was developed in part to treat ebolavirus and then was studied in two other types of coronaviruses, what’s called SARS and MERS and both of them are kind of causes of the novel coronavirus we’re dealing with now.

How many patients are in the remdesivir trial?

We’ve enrolled one person so far. But enrollment across the country is so active these trials might be fully enrolled, even in a couple weeks, the way it’s going.

How has your patient responded?

I understand the patient is doing well but that’s probably all I can say. Because of privacy.

Do you have insights on some of the other vaccine trials?

I don’t have in-depth knowledge. I know there’s a vaccine that was developed in Israel that I understand may start trial as early as June. … There are many people trying to develop vaccines.
[covid-19-tracker]

Coronavirus Patients Rush to Join Studies of Gilead Drug

Coronavirus patients around the world have been rushing to join remdesivir studies that opened in hospitals in the last few weeks.
Interest has been so great that the U.S. National Institutes of Health is expanding its study, which has nearly reached its initial goal of 440 patients. The drug’s maker, California-based Gilead Sciences, is quickly ramping up its own studies, too.
Remdesivir is given through an IV. It’s designed to interfere with an enzyme that reproduces viral genetic material.
Gilead supplied remdesivir for two studies in China. Results are expected by the end of April.

Cost to Produce the Medicines

According to Reuters, a study released Friday in the Journal of Virus Eradication, researchers, including Howard University chemist Joseph Fortunak, examined the cost of manufacturing medicines in recent or ongoing COVID-19 trials.
Using prices for active pharmaceutical ingredients to build estimates, they said Gilead Science’s experimental drug remdesivir, originally for Ebola, could be made for as little as $0.93 for a day’s supply.
Gilead said the figure does not “accurately reflect” manufacturing costs at scale, but it did not give those costs.
Gilead can produce 140,000 remdesivir treatment courses near-term, and 1 million-plus by December, it has projected.

DON'T MISS

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

DON'T MISS

GOP Picks up Key House Seats While Democrats Say They Still Have a Path to a Majority

DON'T MISS

Costa Expands Lead Over Maher, Richardson Holds Narrow Edge on Bonakdar

DON'T MISS

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

DON'T MISS

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

DON'T MISS

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

DON'T MISS

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

DON'T MISS

President-Elect Trump Names Susie Wiles as Chief of Staff

DON'T MISS

Robert F. Kennedy Jr., Foe of Drugmakers and Regulators, Is Poised to Wield New Power

DON'T MISS

California Beat Trump in Court His First Term. It’s Preparing New Cases for His Second.

UP NEXT

California Beat Trump in Court His First Term. It’s Preparing New Cases for His Second.

UP NEXT

Don’t Expect Kamala Harris’ Loss to Boost Gavin Newsom’s Presidential Prospects

UP NEXT

California Governor Calls Special Session to Protect Liberal Policies From Trump Presidency

UP NEXT

Trump’s Deportation Plan Brings Fear and Sadness at CA Border

UP NEXT

Thousands Ordered to Evacuate as Powerful Wind-Fed Wildfire Burns Homes in Southern California

UP NEXT

Hundreds of Californians Flee and Homes Burn as Powerful Winds Feed Wildfires

UP NEXT

Wired Wednesday – Hikers, Off-Roaders React to Proposed Change to Sierra National Forest

UP NEXT

Powerful Winds and Low Humidity Raise Wildfire Risk Across California as Blaze Erupts Near Malibu

UP NEXT

Trump Promises to Bring Lasting Peace to a Tumultuous Middle East. But Fixing It Won’t Be Easy

UP NEXT

Different Faces, Different Voices, But the Same Goal: Exercising Democracy by Voting

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

6 hours ago

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

7 hours ago

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

7 hours ago

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

7 hours ago

President-Elect Trump Names Susie Wiles as Chief of Staff

8 hours ago

Robert F. Kennedy Jr., Foe of Drugmakers and Regulators, Is Poised to Wield New Power

8 hours ago

California Beat Trump in Court His First Term. It’s Preparing New Cases for His Second.

8 hours ago

With Mountain West Title Out of Reach, What Is Fresno State Playing For?

10 hours ago

Former Fresno State Bull Rider, a Vietnam Vet, Calls Central Valley Honor Flight ‘Life-Changing’

10 hours ago

Don’t Expect Kamala Harris’ Loss to Boost Gavin Newsom’s Presidential Prospects

10 hours ago

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

The city of Fresno now owns a new park. Or at least half of it. Technically, the city of Fresno did not own El Dorado Park, at Barstow Avenu...

5 hours ago

5 hours ago

City of Fresno Buys Half of Eldorado Park in Strategic Maxwell-Led Move

The U.S. Capitol is seen from Pennsylvania Avenue in Washington, on Election Day, Tuesday, Nov. 5, 2024. (AP Photo/Jon Elswick)
6 hours ago

GOP Picks up Key House Seats While Democrats Say They Still Have a Path to a Majority

6 hours ago

Costa Expands Lead Over Maher, Richardson Holds Narrow Edge on Bonakdar

6 hours ago

Clovis’ Measure A and Sanger’s Measure M Get Good News with Thursday Vote Update

7 hours ago

President-Elect Trump Has Sweeping Plans. Here’s What He’s Proposed.

7 hours ago

New Look Basketball Bulldogs Open at Home. How Will They Fare Under Walberg?

7 hours ago

Americans Seek Fresh Start Abroad as Election Sparks Expat Interest

Trump co-campaign manager Susie Wiles is seen at Nashville International Airport as Republican presidential candidate former President Donald Trump arrives, July 27, 2024, in Nashville, Tenn. (AP File)
8 hours ago

President-Elect Trump Names Susie Wiles as Chief of Staff

Search

Send this to a friend